CLW improved the diabetic diagnostic criteria by reducing hepatic insulin resistance by potentiating hepatic insulin signaling (pAkt➔pGSK-1β) and lowering hepatic triglyceride contents by increasing the phosphorylation of AMPK in non-obese type 2 diabetic rats. This evidence concerns the gene INS and Insulin resistance.